with dorsal inlay of buccal mucosa and tubularization. Our objective is to evaluate success of each procedure.
INTRODUCTION AND OBJECTIVES:
The artificial urinary sphincter (AUS) is most commonly placed in men with non-neurogenic stress urinary incontinence. In the setting of prior urethral compromise, transcorporal AUS placement is often considered. At present, the generally accepted approach has significant limitations in the degree of urethral protection and conservation of corporal capacity for future restoration of sexual health. Therefore, we offer our alternate approach to transcorporal AUS placement, termed the gullwing modification.
METHODS: In this video, we present a novel technique for transcorporal placement of the AUS, termed the gullwing modification.
RESULTS: After the patient is prepped and draped in the usual sterile fashion, a perineal incision is made and dissection is carried down to the level of the bulbar urethra. Bracket shaped flaps are outlined on the ventral aspect of the tunica albuginea for both flanking segments of corpora cavernosa. These areas are then incised such that flaps can be raised and brought over the ventral urethra. The flaps are then suture approximated to each other using 4-0 Chromic suture. Care is taken to approximate the tissue without tension to avoid urethral compression separate from the AUS cuff. The reinforced urethra is then measured, and a cuff size 0.5 centimeters above measurement is selected to reduce the risk of postoperative urinary retention. Prior to cuff placement, the tunical defect on the ventral corpora cavernosa is measured and covered with a similarly-sized segment of commercially available allograft. The graft is sutured in place with running 4-0 Monocryl suture. After cuff placement, the additional AUS components (pressure regulating balloon, pump) are placed in standard fashion. Flexible cystoscopy is performed while cycling the device to allow visual confirmation of both proper opening and coaptation of the urethra. With the device deactivated, a 12 French silicone catheter is placed per urethra and all incisions are closed in multiple layers of absorbable suture.
CONCLUSIONS: The gullwing modification for transcorporal AUS placement allows for circumferential urethral reinforcement with tunica albuginea from the corpora cavernosa. This provides additional support over prior technique descriptions in an attempt to further prevent subsequent cuff erosion. Additionally, corporal grafting avoids the need to compromise the three-dimensional anatomy relevant to future consideration of a penile prosthesis, if desired. METHODS: This video demonstrates the standardized technique step by step. Antegrade urethral opening pressure and functional urethral length are determined before skin incision in general anesthesia without relaxation. After a perineal vertical midline incision just below the scrotum the bulbocavernous muscle is exposed and splitted. In a next step, an angled guide needle is introduced paraurethrally through the perineal access and is brought up strictly retropubically, lateral to the bladder neck, to the suprapubic skin. Cystoscopy is performed to exclude bladder perforation. A 4 x 2 cm non resorbable porcine dermal skin implant for bulbar urethal protection is sutured onto the 2.5 cm wide partial resorbable polypropylene/ polyglycolic-acidcaprolacton sling. Through the curved -perforated guide needle, the sling is drawn suprapubic with a wire. The suspension elevates the pelvic floor and improves functional urethral coaptation. A transverse suprapubic incision about 6 cm long is made down onto rectus fascia. Gentle pressure of the fist is applied onto the bladder with parallel increase of the sling tension to determine optimal antegrade urethral opening pressure. We aim an increase of the antegrade urethral pressure of 20-25 H20, as well as a prolonged functional urethral length. Repetitive antegrade pressure measurements confirm reliable introperative dynamic adjustement. Once the final pressure is accepted, the polypropylene ends are knotted.
RESULTS: In 2004, initial series showed feasability in 16 patients with social urinary continence rate of 69 %. Midterm term followup results after 36 months in 57 patients confirmed stable 60 % social continence and 14% significant improvement. Pressure-flow studies excluded infravesical obstruction. Only 12% of the patients underwent artificial urinary sphincter implantation in the long-term course.
CONCLUSIONS: The presented bulbourethral suspension technique is a standardized, intraperative adjustable and non obstructive urethral sling technique with high social continence rate and patient statisfaction.
Source of Funding: none

V05-09 ROBOTIC BLADDER NECK CLOSURE IN THE COMPLEX NEUROGENIC BLADDER PATIENT
Unwanaobong Nseyo*, Michael Albo, Andrew Karim Kader, San Diego, CA INTRODUCTION AND OBJECTIVES: The management of the lower urinary tract continence can be complex in patients with neurogenic bladder. Oftentimes, many procedures maybe attempted in an effort to achieve social continence. Often when antispasmodics and urethral bulking agents fail, the native urethra must be abandoned and a bladder neck closure is needed. Traditionally, bladder neck closure has been performed as an open procedure, however, when coupled with a minimally invasive approach, bladder neck closure can be safely and effectively performed in the neurogenic bladder patient while maintaining the advantages associated with robotic surgery. Robotic isolation of the bladder neck is routine for several urologic procedures such as robotic radical and simple prostatectomy and a cystectomy, and therefore we felt that we could easily apply the principles of these techniques to performing a robotic bladder neck closure.
METHODS: We present a case of a SCI patient with neurogenic bladder and a complex history of bladder management. The patient was initially managed by a sphincterotomy and external condom catheter. However, when he began to have issues with the condom catheter, the desire was to restore continence to his bladder outlet. A SPT was placed and despite a trial of anticholinergics and multiple attempts at bulking agents placed at the urethra and bladder neck, the patient continued to have intractable urinary incontinence and the decision was made to proceed with a bladder neck closure. Pre-operative UDS demonstrated an adequate bladder capacity and low storage pressures.
RESULTS: The total operative time was 169 minutes, 134 minutes of which was robotic time. The estimated blood loss was 75ml. Dense scar tissue was noted near the prostatic apex consistent with the prior sphincterotomies. The patient had an uncomplicated postoperative course. He was maintained on his scheduled anticholinergics and at his post-operative visit at 2 and 6 months was noted to not have any leakage per urethra.
CONCLUSIONS: Robotic surgery has transformed many urology surgical procedures which are traditionally performed deep within the pelvis. The benefits of using a robotic surgical approach is even more apparent in situations where there is complex anatomy or where prior surgical procedures make an open approach more challenging. Given the similarities in bladder neck isolation with other standard robotic urologic procedures, robotic bladder neck closure is an appropriate extension of this technique. Robotic bladder neck closure can be a safe treatment option for the complex neurogenic bladder patient. Adjunctive manoeuvres such as corporal splitting, infrapubectomy and corporal rerouting are sometimes necessary to achieve a tension-free anastomosis. Corporal rerouting is rarely necessary, therefore rarely performed. Our objective is to detail the surgical steps and technique for the above-mentioned procedures.
METHODS: Our case is that of a 14-year-old boy with PFUI secondary to a motor vehicle accident. The patent was initially managed with a percutaneous suprapubic tube and underwent urethral rest for 3 months. Pre-operative combined retrograde urethrogram and antegrade flexible cystoscopy showed a 6cm distraction defect. Posterior urethroplasty was performed, using corporal splitting, infrapubectomy and corporal rerouting, as detailed in the video.
RESULTS: The post-operative course was uneventuful and post-operative imaging perfomed 1 month later showed an open and patient urethra with no extravasation. The patient was doing well at his 6-month post-operative visit.
CONCLUSIONS: Adjunctive manoeuvres during posterior urethroplasty may be necessary to obtain a tension-free anastomosis. Knowledge of the surgical techniques is essential for successful surgical outcomes.
Source of Funding: None
V05-11 NEW ADJUSTABLE ARTIFICIAL URETHRAL SPHINCTER (AUS) WITH AN ADDITIONAL STRESS BALLOON FURTHER IMPROVES TREATMENT OUTCOME IN MALE STRESS URINARY INCONTINENCE (SUI)
Karl-Dietrich Sievert*, Detmold, Germany; Ghazal Ameli, Korneuburg, Austria; Alfons Gunnemann, Detmold, Germany; Wilhelm Huebner, Korneuburg, Austria INTRODUCTION AND OBJECTIVES: The artificial urinary sphincter (AUS) became the gold standard to treat stress urinary incontinence (SUI) in the male. The reported success rate varied between 50 to 96%. Still, certain issues seem not to be solved. The recently released AUS Victoþ from PromedonÒ has been developed to solve these issues: faster reaction to stress, less episodes of urine loss, adjustable cuff to ensure the critical urethral closing pressure in order to avoid atrophy of the corpora spongiosum. We demonstrate the Victoþ surgical procedure and demonstrate its safety and efficacy.
METHODS: We retrospectively reviewed data stored in a multicenter prospective database of 46 (average age:70AESD 7,5y) male patients with severe SUI. SUI resulted due to previous TURP, radical prostatectomy and even radiation followed by TURP related to prostate cancer. The implantation of the all-in-one VictoþAUS is performed in the lithotomy position through a midline perineal and inguinal incision. Patients were followed from 11 (0,9-20,9) months. The essential features of the operation are described. Primary successful operative measurements were defined as no complications and patient satisfaction. Successful treatment outcome was defined as no pad usage to reduction of pad usage > 50%.
RESULTS: No pre-and intra-operative complications were recorded. The operating time was 63 (55-78) min. After 6.5(5-7) weeks the patient returned for activation. 18/36 patients became continent with the initial filling, whereas others needed additional fluid to reach a satisfactory outcome. After the optimal filling of the VictoþAUS, the need for pads was reduced from 6,4AE3,6 to 1,8AE1,8 pads/day. Overall patient satisfaction was reported in 84% of the patients. Patients were also investigated regarding their leakage while coughing using the stress balloon. Leakage while coughing was not seen in any of patients.
CONCLUSIONS: The initial results of the new VictoþAUS appears that it can be safely and effectively performed with promising results.
Source of Funding: None
V05-12 PENILE SKIN FLAP NEOURETHRA AFTER RADICAL PENILE AMPUTATION
Sanjay Kulkarni*, Ayman Mousa, Shreyas Badranavar, Amar Rawal, Pankaj Joshi, Pune, India INTRODUCTION AND OBJECTIVES: Squamous cell carcinoma of the urethra is rare. Traditional treatment for bulbar urethral cancer is decided by the local extent of the disease and varies from wide local excision to total amputation of the penis. The treatment involves total penectomy with cystoprostato urethrectomy and ileal conduit. The local recurrence after such a major surgery is high and five-year survival is less than 20%. Those patients who refused ileal conduit, we discussed all the alternatives. To preserve natural voiding, we describe a new technique of penile skin flap neourethra after radical penile amputation.
METHODS: 5 Patients are included in the series. All patients presented with lump in the perineum. In two patients, the lumps were incised thinking that they were periurethral abscesses by the referring surgeon. Two patients were referred after first stage of Johansson's urethroplasty for non-healing of the wound. One patient was diagnosed on endoscopy. Histopathology was squamous cell carcinoma of the urethra. MRI scan was performed to check the local extent of the
